In 2023, the mortality rate for bladder malignant neoplasms in Japan was 7.8 deaths per hundred thousand persons. Forecasts indicate a gradual increase, reaching 8.7 by 2028. Year-on-year, the mortality rate grows by an average of 2.2%. Observing the last two years, the increase was steady, aligning with long-term growth trends. The compound annual growth rate (CAGR) over five years projects a modest annual increase of 2.2%.
Future trends to watch for include advancements in medical technology that could impact early detection and treatment, potentially stabilizing or reducing mortality rates despite demographic pressures such as an aging population.
